Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
about
Cancer cells with irons in the fireELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsExpanding the utility of beta-galactosidase complementation: piece by piece.Targeting iron metabolism in drug discovery and deliveryAndrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cellsImmunophenotyping invasive breast cancer: paving the road for molecular imagingGeneration and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion proteinBlood classical monocytes phenotype is not altered in primary non-small cell lung cancer.DACH1: its role as a classifier of long term good prognosis in luminal breast cancer.Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survivalProteomic-based biosignatures in breast cancer classification and prediction of therapeutic response.Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene NetworksIntracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression.Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.Frontiers in Suicide Gene Therapy of Cancer.Iron-targeting antitumor activity of gallium compounds and novel insights into triapine(®)-metal complexes.Cytotoxic Activities of Silver Nanoparticles and Silver Ions in Parent and Tamoxifen-Resistant T47D Human Breast Cancer Cells and Their Combination Effects with Tamoxifen against Resistant Cells.Gallium-containing anticancer compounds.Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasia.Iron and cancer: recent insightsInhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.Cellular iron metabolism in prognosis and therapy of breast cancer.Suicide Gene Therapy for Cancer - Current Strategies.Iron and reactive oxygen species: friends or foes of cancer cells?DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.Peritubular myoid cell-derived factors and its potential role in the progression of testicular germ cell tumours.The importance of nonpharmacogenetic factors in endocrine therapy.Receptor-based targeting of therapeutics.Non-invasive (89)Zr-Transferrin PET Shows Improved Tumor Targeting Compared to (18)F-FDG PET in MYC-overexpressing Human Triple Negative Breast Cancer.Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma.Microfluidic cell surface antigen expression analysis using a single antibody type.Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7.A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer.Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1.Mechanism of the antitumoral activity of deferasirox, an iron chelation agent, on mantle cell lymphoma.Inactivation of MYO5B promotes invasion and motility in gastric cancer cells.Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population.
P2860
Q26851312-C771F8AB-CD4D-47B6-8D5E-271079E5A55FQ27345430-FD1FCC53-77E9-424B-A000-A999D81657E6Q33715334-763B3AD6-5AF3-4C4F-AE06-25CA69DB2CEBQ33757232-8659B332-B245-4C40-8E54-365EDA99B370Q33772886-534098DF-97BF-4215-8E15-7015CD1C73CCQ34303266-F006898F-F173-49E9-999A-C3D15B43766BQ34494802-42736379-F96E-4E0D-9D43-B67E690FCC0CQ34657618-34219BBA-B757-462B-9462-65F2A37A6C1AQ35083398-F753DA6B-911D-4800-8CBB-2F90ADADE2DEQ35371875-05B2590B-5596-47C7-BD18-177B9EDB94D5Q35450400-C9D32D55-059D-4587-B827-CE3485E432B5Q35752214-85E76BA1-A171-4E1B-A5EE-DCA09300EFF7Q36180381-3BEFE52B-9AD4-4568-ADB3-638600A397C1Q36487046-A62A62CD-1656-40F3-AF20-988042D22851Q36534930-005405BE-DAC9-44EA-AA85-4D6884174E0FQ36568904-97B5D0D8-B6BE-4C0A-A024-9CDD6A17AADDQ36571327-5CDE5BD4-8716-4EEF-8617-9D303246A9D7Q36616612-7719EC9F-9916-4D8F-82C8-184414B2C1D9Q36638101-D263A44A-38E1-48FD-8841-49F518249EE0Q36909297-DADD0E26-FB52-4AD9-B050-A66AAE67F6E9Q37068080-0FCE06A8-7B70-47BC-A581-DA408A0408B8Q37077422-9DE69756-6F33-429D-A337-2D3C473B3819Q37347017-3B3E108A-24E3-469C-BE9A-F473C7ABC22DQ37667481-3E2468D4-03CD-460D-9D41-BD92A1134C4DQ37686041-68DE759C-A139-457A-976C-E0BEA1E60553Q37690976-03947330-9F6E-4963-9CE3-DCB7CF834420Q37701609-6DDD6DF4-3C7D-4EC9-96D8-8498F74CEB55Q37882002-C5F2C52D-8B9C-4F03-8326-279A20F8CB8CQ38003706-FF1A2EFF-2252-4280-B555-5E3F1DEB6857Q38084739-CD021D14-C7A3-4CCD-A942-0514E7BB94A2Q38605112-49CAB0A4-8AFE-414D-9E62-0699CD290CFCQ38637192-76F43F53-5DC0-40D5-9AC1-B3DFDB974F0BQ38799208-4C2FFDD5-C26D-4E2A-BF82-0C691507F2D6Q38900933-E77AF44A-4FD7-48DD-AC78-4193011D9277Q38920237-DC610D23-34DF-473C-A334-12245222429CQ39012698-6E30860C-DAD2-48ED-B18C-45ECD86BE1C4Q39054949-5AAAF735-08EB-4BE1-86DF-292AD48F38D4Q39269756-0C9752C9-5486-4086-A582-9622676DD688Q39434310-AD169365-1FE9-4FE0-A36F-42F44FD4A70CQ40248157-2F0D6DC4-76C7-4BE2-927E-101C56BF741C
P2860
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Transferrin receptor (CD71) is ...... predict response to tamoxifen.
@en
Transferrin receptor
@nl
type
label
Transferrin receptor (CD71) is ...... predict response to tamoxifen.
@en
Transferrin receptor
@nl
prefLabel
Transferrin receptor (CD71) is ...... predict response to tamoxifen.
@en
Transferrin receptor
@nl
P2093
P2860
P50
P1476
Transferrin receptor (CD71) is ...... predict response to tamoxifen
@en
P2093
Cindy M Staka
Desmond G Powe
E Claire Paish
Hany Onsy Habashy
R Douglas Macmillan
Robert I Nicholson
P2860
P2888
P304
P356
10.1007/S10549-009-0345-X
P407
P577
2009-02-24T00:00:00Z